F13.188
Sedative, hypnotic or anxiolytic abuse with other sedative, hypnotic or anxiolytic-induced disorder
Clinical Classification Guidelines
Medical Intelligence & Overview
ICD-10 code F13.188 refers to a condition where an individual misuses sedative, hypnotic, or anxiolytic medications and experiences other disorders caused by these substances. These medicines are often prescribed to help with anxiety, sleep issues, or as calming agents. However, when misused, they can lead to serious health problems. This article aims to clarify what this condition entails, its causes, symptoms, how it is diagnosed, and treatment options.
Causes & Symptoms
Clinical Causes: Prescription misuse or overuse of sedatives, hypnotics, or anxiolytics. Self-medication to manage stress, anxiety, or sleep problems without medical guidance. Psychological factors such as trauma, depression, or other mental health disorders driving substance misuse. Social influences, including peer pressure or environments where substance misuse is common. History of substance abuse or addiction, increasing the likelihood of misuse of prescribed medications.
Key Symptoms: Craving or a strong desire to use sedatives, hypnotics, or anxiolytics. Repeated unsuccessful attempts to cut down or control use. Spending a significant amount of time obtaining, using, or recovering from the effects of the substances. Neglecting responsibilities at work, school, or home due to substance use. Using larger amounts or over longer periods than intended. Experiencing withdrawal symptoms like sweating, shaking, nausea, or anxiety when not using the drug. Continuing use despite clear evidence of harmful effects or problems caused by the substances.
Diagnostic & Treatment
Diagnosis Path: Diagnosis involves a detailed medical and psychological assessment. Healthcare providers evaluate the individual's history of sedative, hypnotic, or anxiolytic use, including patterns, dosage, and-related behaviors. They also assess for associated mental health issues and may perform physical examinations or laboratory tests to rule out other conditions. Usually, diagnosis follows criteria outlined in psychiatric standards such as the DSM-5, focusing on problematic substance use and related disorders.
Treatment Protocols: Detoxification and management of withdrawal symptoms under medical supervision. Psychotherapy, including cognitive-behavioral therapy (CBT), to address substance use behaviors and underlying issues. Medication-assisted treatment (MAT) where appropriate, possibly including alternative medications to stabilize mood or reduce cravings. Educational programs to improve understanding of substance misuse and prevent relapse. Support groups and community resources to provide ongoing encouragement and accountability. Addressing co-occurring mental health conditions to support overall recovery.
Clinical Advice & FAQs
Billing Guidance
Is F13.188 a billable ICD-10 code?
Yes, F13.188 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report F13.188?
Clinical documentation must specify the nature of Sedative, hypnotic or anxiolytic abuse with other sedative, hypnotic or anxiolytic-induced disorder and any associated comorbidities for accurate reporting.
Cite this Clinical Reference
